Frederick Naftolin is the Chief Scientific Officer at e-Bio Corp, a position held since 2019. They co-founded Interactome Biotherapeutics in 2024 and contribute to advancements in the field. Previously, Frederick served as a Professor and Chair of Obstetrics and Gynecology at Yale University and New York University, and was a Professor and Chair at McGill University earlier in their career. They earned a D. Phil. from the University of Oxford and a Doctor of Medicine degree from the University of California, San Francisco, along with a Bachelor of Arts in Pre-Medicine from UCLA and UC Berkeley. Currently, Frederick is still in residency in obstetrics and gynecology at UCLA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices